• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Using TBK1, a Novel Molecule Which Controls the Adjuvancticity of DNA Vaccines, to Improve DNA Vaccine Immunogencity against Malaria

DNA vaccines, which can elicit killer T-cell response, have thus far failed to elicit reliable, strong immune response in humans. Cevayir Coban of Osaka University in Japan will use newly identified intracellular signaling molecules as components of DNA vaccines against malaria.

More information about Create New Ways of Protecting Against Infectious Diseases (Round 1)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.